Trevena GPCR Platform Yields a Novel Mu-Opioid Biased Ligand Analgesic with Side Effect Benefits

News   Jan 24, 2013

 
Trevena GPCR Platform Yields a Novel Mu-Opioid Biased Ligand Analgesic with Side Effect Benefits
 
 
 
 

RELATED ARTICLES

U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast Milk

News

The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.

READ MORE

CRISPR Reveals New Targets for Promising Cancer Drugs

News

Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.

READ MORE

BioAscent Announces New CEO and Plans to Expand Discovery Services Offering

News

BioAscent Discovery Limited appoints new CEO, Paul Smith in preparation for the expansion of companies discovery services.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE